The sphingosine kinase inhibitor 2‐(p‐hyroxyanilino)‐4‐(p‐chlorophenyl)thiazole reduces androgen receptor expression via an oxidative stress‐dependent mechanism
Open Access
- 31 October 2012
- journal article
- research article
- Published by Wiley in British Journal of Pharmacology
- Vol. 168 (6) , 1497-1505
Abstract
Background and Purpose: Sphingosine kinase catalyses the formation of sphingosine 1‐phosphate and is linked with androgen receptor signalling in prostate cancer cells. Therefore, we investigated the effect of sphingosine kinase inhibitors on androgen receptor expression.Experimental Approach: Androgen‐sensitive LNCaP cells were treated with SKi (2‐(p‐hydroxyanilino)‐4‐(p‐chlorophenyl)thiazole), which inhibits sphingosine kinases 1 and 2 activity, and the effect on androgen receptor expression was measured.Key Results: Treatment of cells with SK1 inhibitors reduced the expression of the androgen receptor and prostate‐specific antigen, while (R)‐FTY720 methyl ether (a sphingosine‐kinase‐2‐selective inhibitor), at a concentration that eliminates sphingosine kinase 2 from cells, had no significant effect on androgen receptor expression. The effect of SKi on androgen receptor expression was independent of the SKi‐induced proteasomal degradation of SK1 and was post translational, although androgen receptor mRNA transcript was reduced. Fumonisin B1 (a ceramide synthase inhibitor) also failed to reverse the effect of SKi on androgen receptor expression, thereby excluding a role for ceramide derived from the salvage pathway. The effect of SKi on androgen receptor expression was reversed by N‐acetylcysteine, which was used to scavenge reactive oxygen species.Conclusion and Implications: Inhibition of sphingosine kinase 1 activity abrogates androgen receptor signalling via an oxidative stress‐induced, p53‐independent mechanism in prostate cancer cells. Therefore, SK1 inhibitors may offer therapeutic potential in promoting the removal of AR receptors from prostate cancer cells, resulting in an increased efficacy, which is likely to be superior to inhibitors that simply reversibly inhibit AR signalling.Keywords
This publication has 41 references indexed in Scilit:
- (R)-FTY720 methyl ether is a specific sphingosine kinase 2 inhibitor: Effect on sphingosine kinase 2 expression in HEK 293 cells and actin rearrangement and survival of MCF-7 breast cancer cellsCellular Signalling, 2011
- The curcumin analog ca27 down‐regulates androgen receptor through an oxidative stress mediated mechanism in human prostate cancer cellsThe Prostate, 2011
- Defining a role for sphingosine kinase 1 in p53-dependent tumorsOncogene, 2011
- FTY720 Analogues as Sphingosine Kinase 1 InhibitorsJournal of Biological Chemistry, 2011
- The Sphingosine Kinase 1 Inhibitor 2-(p-Hydroxyanilino)-4-(p-chlorophenyl)thiazole Induces Proteasomal Degradation of Sphingosine Kinase 1 in Mammalian CellsJournal of Biological Chemistry, 2010
- FTY720 and (S)-FTY720 vinylphosphonate inhibit sphingosine kinase 1 and promote its proteasomal degradation in human pulmonary artery smooth muscle, breast cancer and androgen-independent prostate cancer cellsCellular Signalling, 2010
- Chiral Vinylphosphonate and Phosphonate Analogues of the Immunosuppressive Agent FTY720The Journal of Organic Chemistry, 2009
- Deactivation of Sphingosine Kinase 1 by Protein Phosphatase 2AJournal of Biological Chemistry, 2008
- A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteinsCancer and Metastasis Reviews, 2008
- Sphingosine 1-phosphate signalling in mammalian cellsBiochemical Journal, 2000